Description

Robot-assisted surgery allows doctors to perform many types of complex procedures with more precision, flexibility and control than is possible with conventional techniques. Robotic surgery is usually associated with minimally invasive surgery-procedures performed through tiny incisions. The global robot-assisted surgical devices market is set to increase by US$ 9,705 million from 2022 to 2028, representing a compound annual growth rate (CAGR) of 14.8% during the forecast period.

The global robot-assisted surgical devices market is highly competitive. The key players in the robot-assisted surgical devices market include Asensus Surgical Inc., Auris Health Inc. (Johnson & Johnson), Brainlab AG, CMR Surgical Ltd., Corindus Vascular Robotics Inc. (Siemens Healthineers AG), Globus Medical Inc., Intuitive Surgical Inc., Medtronic plc, Robocath S.A.S., Smith & Nephew plc, Stereotaxis Inc., Stryker Corporation, Zimmer Biomet Holdings Inc.

The report is an invaluable resource for companies and organizations active in this industry. It provides a cohesive picture of the robot-assisted surgical devices market to help drive informed decision making for industry executives, policy makers, academic, and analysts.

Report Scope

Years considered: this report covers the period 2018 to 2028

Key Benefits for Stakeholders

– Get a comprehensive picture of the global robot-assisted surgical devices market
– Identify regional strategies and strategic priorities on the basis of local data
– Pinpoint growth sectors and trends for investment

Table of Contents

Part 1. Introduction
> Study period
> Geographical scope
> Research methodology
Part 2. Robot-assisted surgical devices market overview
Part 3. Key companies
> Asensus Surgical, Inc.
> Auris Health, Inc. (Johnson & Johnson)
> Brainlab AG
> CMR Surgical Ltd.
> Corindus Vascular Robotics, Inc. (Siemens Healthineers AG)
> Globus Medical, Inc.
> Intuitive Surgical, Inc.
> Medtronic plc
> Robocath S.A.S.
> Smith & Nephew plc
> Stereotaxis Inc.
> Stryker Corporation
> Zimmer Biomet Holdings, Inc.
About StrategyHelix
Disclaimer